Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells
Due to the success of chimeric antigen receptors (CARs) in hematological tumors, CARs are also being studied to treat solid tumors. Improving the ability of CARs to penetrate solid tumor tissues is one of the biggest challenges. As the most malignant cancer of the female reproductive system, the sur...
Main Authors: | Liang Wang, Rulin Yang, Liping Zhao, Xiwen Zhang, Tianmin Xu, Manhua Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219323674 |
Similar Items
-
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells
by: Alfieri, M., et al.
Published: (2022) -
New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms
by: Anna Gorrasi, et al.
Published: (2020-11-01) -
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
by: Oh F, et al.
Published: (2018-09-01) -
Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018-09-01) -
Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion
by: Matthew G. Annis, et al.
Published: (2018-01-01)